Castration induced changes in dog prostate gland associated with diminished activin and activin receptor expression.
This study was conducted to evaluate the effect of androgen ablation on dog prostate gland structure and the proliferation capacity of the prostatic cells and their association with the expression of Activin A and Activin RIIA receptor. The effect of androgen on the prostate gland was compared in intact and castrated dogs after one and two weeks. Specific primary antibodies were used to immunolocalize activin-A, activin receptor type II A and the proliferation marker (PCNA). The results showed that the glandular acini of the prostate gland of intact dogs are lined by tall columnar secretory cells and less abundant flattened basal cells and surrounded by a thin fibromuscular tissue. The cytoplasm of the glandular cells exhibited an intense immunoreaction for activin A and activin RIIA receptor while basal cells expressed PCNA. Castration induced a remarkable atrophy of the prostatic acini associated with a progressive loss of secretory epithelial cells, which showed a dramatic decrease to complete disappearance of Activin A and Activin RIIA receptor immunoreactions. The remaining cells of the atrophied acini continue to express PCNA and the inter-acinar fibromuscular tissue showed a remarkable increase in its mass and are induced to express PCNA. These results indicated that androgen is required for the survival of epithelial cells and to maintain growth-quiescent fibromuscular cells, while basal cell proliferation is androgen independent. The changes in the Activin A and Activin RIIA receptor localization and their association with the dynamic pattern of prostate gland regression after castration suggested that Activin A and Activin RIIA receptor expression are androgen dependent.
Al-Omari
Ruba
R
Department of Basic Veterinary Medical Sciences, Faculty of Veterinary Medicine, Jordan University of Science and Technology, P.O. Box 3030, Irbid, Jordan.
Shidaifat
Falah
F
Dardaka
Mousa
M
D030301:Activin Receptors, Type II / Q000378:metabolism*; D028341:Activins / Q000378:metabolism*; D000728:Androgens / Q000378:metabolism; D000818:Animals; D003593:Cytoplasm / Q000378:metabolism; D004285:Dogs; D005786:Gene Expression Regulation; D007150:Immunohistochemistry / Q000662:veterinary; D028322:Inhibin-beta Subunits / Q000378:metabolism*; D008297:Male; D009919:Orchiectomy / Q000662:veterinary*; D018809:Proliferating Cell Nuclear Antigen; D011467:Prostate / Q000166:cytology / Q000378:metabolism*
D000728:Androgens; D018809:Proliferating Cell Nuclear Antigen; C422405:activin A; D028341:Activins; D028322:Inhibin-beta Subunits; D030301:Activin Receptors, Type II; C425585:activin receptor type II-A